Canary Capital, a digital asset manager, has filed with the U.S. Securities and Exchange Commission (SEC) for a Staked Injective (INJ) ETF.
Plans for Staked Injective ETF
On July 17, Canary Capital filed for a Staked Injective ETF, outlining plans to provide investors with a regulated means of gaining exposure to INJ while earning staking rewards.
Growing Interest in Staking ETFs
The proposed ETF will track the price of INJ and distribute staking yields, following a trend of increasing interest in staking-related products. Canary Capital aims to remove technical hurdles and offer a compliant way for more people to invest.
Technological Advances and Support for Injective
Injective is a high-speed blockchain that supports both TradFi and DeFi applications, recently adding full EVM support, enhancing compatibility with existing Ethereum-based apps. Backed by notable investors, Injective continues to receive significant interest.
Canary Capital's ETF filing highlights the increasing interest in crypto-related investment products and underscores the demand for safe and regulated financial tools in this space.
